Start Date
November 30, 2012
Primary Completion Date
June 30, 2014
Study Completion Date
July 31, 2014
LDE-225
LDE-225 capsules will be administered as a fixed dose of 800 mg daily for two weeks.
Rutgers Cancer Institute of New Jersey, New Brunswick
Collaborators (1)
Rutgers Cancer Institute of New Jersey
OTHER
National Cancer Institute (NCI)
NIH
Novartis Pharmaceuticals
INDUSTRY
Rutgers, The State University of New Jersey
OTHER